VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
TLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
TLXTelix Pharmaceuticals Limited
$8.96$3.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTLXQuarterly Cash Flow

Telix Pharmaceuticals Limited (TLX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Telix Pharmaceuticals Limited (TLX) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

TLX Cash Flow Statement

Quarterly statement

TLX Cash Flow Statement

Telix Pharmaceuticals Limited (TLX) cash flow statement — 9-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17
Cash from Operations22.97M-34.73M16.15M3.95M34.98M10.63M13.26M-3.75M-60.22M-30.68M-28.65M20.43M-18.47M-8.22M-15.11M-13.44M-7.22M-4.04M-1.99M
Operating CF Margin %4.83%-8.47%4.55%0.66%18.51%3.77%6%-2.76%-250.42%-654.72%-984.47%566.61%-1149.47%-492.89%-831.58%-6890.79%---
Operating CF Growth %42.27%-979.66%-53.84%-62.84%163.82%383.26%122.02%87.77%-110.2%-250.16%-55.09%348.59%-22.22%38.83%-109.45%-232.31%-262.97%--
Net Income38.22M-4.79M-2.09M20.27M29.37M19.53M-14.32M-33.19M-70.89M-48M-32.51M-26.59M-18.3M-17.5M-10.37M-8.64M-5.19M-4.81M-1.57M
Depreciation & Amortization25.62M11.82M9.59M4.32M3.76M3.71M3.3M2.66M2.62M2.63M2.55M2.55M2.33M1.91M2.32M5.07K1.93K3.79K0
Stock-Based Compensation0010.54M9.72M9.83M7.47M1.31M5.84M2.27M-767K2.09M787K1.56M615K654K422.92K289.08K109.02K0
Deferred Taxes0000000000000000000
Other Non-Cash Items-40.87M-41.76M-1.9M68.47M-7.98M37.44M22.96M49.58M5.78M22.87M-769K44.3M-4.07M10.09M-7.72M3.48M-2.32M1.54M-416.53K
Working Capital Changes000-98.82M0-57.53M0-28.64M0-7.42M0-612K0-3.34M0-8.7M0-890.22K0
Change in Receivables000-57.08M0-27.38M0-19.93M0-7.19M0-328K0-3.63M0-7.22M0-338.8K0
Change in Inventory000-3.24M0-9.64M0-5.02M0-2.82M0-91K0101K00000
Change in Payables0000000000000000000
Cash from Investing-33.62M-27.21M-237.32M-89.33M-45.62M-22.6M-2.89M-5.66M-11.34M-1.95M-778K-447K-644K-357K-111K14.46M-15.74M-1.26K0
Capital Expenditures-19.24M-27.46M-25.99M-9.63M-4.6M-6.67M-3.01M-4.66M-2.37M-1.01M-329K-48K-200K-343K-60K70.52K-70.52K-5.64K0
CapEx % of Revenue4.04%6.7%7.32%1.62%2.43%2.37%1.36%3.43%9.87%21.55%11.31%1.33%12.45%20.57%3.3%36.16%---
Acquisitions03.65M-205.97M-11.46M-23.35M-1.61M123K-973K000-322K000-2.69M04.38K0
Investments-------------------
Other Investing-13.38M-3.33M-4.6M-68.24M-17.68M-14.33M0-25K-8.96M-938K-449K-77K-444K-14K-51K17.08M-15.67M00
Cash from Financing118.1M-793.55K-2.68M636.77M2.13M5.49M4.7M3.79M171.17M2.51M339K33.63M486K43.16M-432K-893.81K046.9M7.89M
Debt Issued (Net)120.67M159.04K-413.47K01.5M01.77M0-431K0-511K067K0-432K-88K0-778.63K0
Equity Issued (Net)1.36M1.12M619.75K0000000000000048.51M0
Dividends Paid0000000000000000000
Share Repurchases0000000000000000000
Other Financing-3.93M-2.08M-2.89M636.77M629.66K5.49M2.93M3.79M171.6M2.51M850K33.63M419K43.16M0-805.81K0-826.2K7.89M
Net Change in Cash109.38M-64.64M-213.23M591.51M-7.07M-8.49M15.4M-6.28M100.57M-27.58M-28.33M53.57M-20.22M34.45M-15.63M-1.91M26.37M-5.9M5.9M
Free Cash Flow4.06M-61.2M10.08M-5.68M30.38M3.96M10.25M-8.41M-62.59M-31.69M-28.98M20.38M-18.67M-8.56M-15.17M-13.46M-7.29M-4.05M-1.99M
FCF Margin %0.85%-14.92%2.84%-0.96%16.08%1.4%4.64%-6.19%-260.29%-676.27%-995.77%565.28%-1161.92%-513.46%-834.88%-6903.85%---
FCF Growth %-59.73%-976.46%-66.82%-243.74%196.4%147%116.38%73.45%-116.01%-255.47%-55.19%338.08%-23.05%36.4%-108.25%-232.48%-266.52%--
FCF per Share0.01-0.180.03-0.020.090.010.03-0.03-0.20-0.11-0.100.08-0.07-0.04-0.07-0.07-0.04-0.02-0.02
FCF Conversion (FCF/Net Income)0.60x7.25x-7.74x0.10x1.19x0.54x-0.93x0.11x0.85x0.64x0.88x-0.77x1.01x0.47x1.46x1.56x1.39x0.84x0.63x
Interest Paid008.94M4.06M662.65K429K356K299K109K115K74K163K28K102K15K17K05.3K0
Taxes Paid0000000000000000000